PRENETICS GLOBAL LTD

Insider buying signals confidence in Prenetics’ new FDA‑cleared NGS panel, strong safety data, and growing retail footprint—an insider‑driven case for future growth.

Explore how Cheng Yin Pan’s RSU exercise signals confidence in Prenetics, its rapid‑molecular diagnostics growth, and regulatory‑tech trends shaping the market.

Insightful analysis of Prenetics Global’s insider holdings, RSU‑driven dilution, and market dynamics reveals how CFO stakes and regulatory wins could shape its growth in genetic testing.